
Opinion|Videos|April 25, 2024
Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer
GU medical oncologist Dr. Rana McKay and urologist Dr. Neal Shore explore how predictive biomarkers and genetic testing are informing risk assessment and guiding personalized treatment decisions in clinical practice.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
HHS requests testosterone therapy label updates, citing new safety data
2
Unmet needs and emerging solutions in MRI-guided prostate cancer care
3
Enzalutamide plus talazoparib demonstrates clinical activity in mHSPC
4
Mina Fam, MD, highlights significance of tebipenem pivoxil approval for cUTI
5














